Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meletios A Dimopoulos

Showing results (121-130 of 740) with videos related to

Pageof 74
Sort By:
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|August 31, 2020
Current trends in the management and prevention of human papillomavirus (HPV) infectionIoannis Ntanasis-Stathopoulos, Anastasios Kyriazoglou, Michalis Liontos, et al.
Hemasphere|February 24, 2021
SARS-CoV-2 Vaccines in Patients With Multiple MyelomaMaria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Eleni Korompoki, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|July 16, 2011
The role of the cell adhesion molecules (integrins/cadherins) in prostate cancerAlexandros Drivalos, Athanasios G Papatsoris, Michael Chrisofos, et al.
Cancer Treatment Reviews|November 27, 2019
Multiple myeloma: Role of autologous transplantationIoannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Efstathios Kastritis, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 23, 2016
Cytogenetics and Survival of Multiple Myeloma: Isolated and Combined EffectsTheodoros N Sergentanis, Efstathios Kastritis, Evangelos Terpos, et al.
Urology|March 18, 2008
Wegener's granulomatosis presenting as a renal massMaria Roussou, Stavros K Dimopoulos, Meletios A Dimopoulos, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 8, 2010
Bortezomib as a treatment option in patients with Waldenström macroglobulinemiaMeletios A Dimopoulos, Christine Chen, Efstathios Kastritis, et al.
Cancer Treatment Reviews|May 22, 2012
Treatment with lenalidomide and dexamethasone in patients with multiple myeloma and renal impairmentMeletios A Dimopoulos, Evangelos Terpos, Hartmut Goldschmidt, et al.
Annals of Translational Medicine|January 13, 2021
Circulating tumor DNA-based predictive biomarkers in breast cancer clinical trials: a narrative reviewOraianthi Fiste, Michael Liontos, Konstantinos Koutsoukos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2005
Extent of damage and repair in the p53 tumor-suppressor gene after treatment of myeloma patients with high-dose melphalan and autologous blood stem-cell transplantation is individualized and may predict clinical outcomeMeletios A Dimopoulos, Vassilis L Souliotis, Athanasios Anagnostopoulos, et al.
Pageof 74

Showing results (121-130 of 740) with videos related to

Sort By:
Pageof 74
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|August 31, 2020
Current trends in the management and prevention of human papillomavirus (HPV) infectionIoannis Ntanasis-Stathopoulos, Anastasios Kyriazoglou, Michalis Liontos, et al.
Hemasphere|February 24, 2021
SARS-CoV-2 Vaccines in Patients With Multiple MyelomaMaria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Eleni Korompoki, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|July 16, 2011
The role of the cell adhesion molecules (integrins/cadherins) in prostate cancerAlexandros Drivalos, Athanasios G Papatsoris, Michael Chrisofos, et al.
Cancer Treatment Reviews|November 27, 2019
Multiple myeloma: Role of autologous transplantationIoannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Efstathios Kastritis, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 23, 2016
Cytogenetics and Survival of Multiple Myeloma: Isolated and Combined EffectsTheodoros N Sergentanis, Efstathios Kastritis, Evangelos Terpos, et al.
Urology|March 18, 2008
Wegener's granulomatosis presenting as a renal massMaria Roussou, Stavros K Dimopoulos, Meletios A Dimopoulos, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 8, 2010
Bortezomib as a treatment option in patients with Waldenström macroglobulinemiaMeletios A Dimopoulos, Christine Chen, Efstathios Kastritis, et al.
Cancer Treatment Reviews|May 22, 2012
Treatment with lenalidomide and dexamethasone in patients with multiple myeloma and renal impairmentMeletios A Dimopoulos, Evangelos Terpos, Hartmut Goldschmidt, et al.
Annals of Translational Medicine|January 13, 2021
Circulating tumor DNA-based predictive biomarkers in breast cancer clinical trials: a narrative reviewOraianthi Fiste, Michael Liontos, Konstantinos Koutsoukos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2005
Extent of damage and repair in the p53 tumor-suppressor gene after treatment of myeloma patients with high-dose melphalan and autologous blood stem-cell transplantation is individualized and may predict clinical outcomeMeletios A Dimopoulos, Vassilis L Souliotis, Athanasios Anagnostopoulos, et al.
Pageof 74